Please login to the form below
Proteostasis Therapeutics
This page shows the latest Proteostasis Therapeutics news and features for those working in and with pharma, biotech and healthcare.
Setback for Vertex’s cystic fibrosis challenger Proteostasis
Unlikely to match market leader's triple therapy. Proteostasis Therapeutics has suffered a major blow to its challenge to Vertex and its portfolio of cystic fibrosis medicines. ... The news sent Proteostasis shares crashing down 63% yesterday - while
Latest news
-
AbbVie and C2N take tau antibody into clinic
Other companies working on tau as a target include TauRx Therapeutics, which has a phase III trial ongoing of its lead candidate LTX in Alzheimer's and is due to report ... Meanwhile, Biogen licensed rights to a tau-targeting compound in development at
-
Astellas earmarks up to $1.2bn for protein folding research
Astellas has teamed up with US company Proteostasis Therapeutics to investigate new ways of treating diseases caused by protein defects, an emerging field of pharmaceutical research. ... Astellas will work with Proteostasis initially on one undisclosed
-
Elan and Proteostasis partnership
Elan Corporation has announced it is to partner with Proteostasis Therapeutics on a platform to discover and develop small molecule drugs and diagnostics for the treatment of neurodegenerative disorders. ... There will also be an opportunity for
More from news
Approximately 1 fully matching, plus 3 partially matching documents found.
Latest Intelligence
-
Deal Watch table for November 2014
Company divestment. 1, 530. Proteostasis Therapeutics / Astellas. Therapeutics modulating Unfolded Protein Response - multiple programmes. ... Cerdelga (eliglustat) sold by Vertex. Acquisition 75% royalty stream. 66. Five Prime Therapeutics / BMS.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest appointments
-
Proteostasis Therapeutics strengthens leadership team
James DeTore, Geoffrey Gilmartin and Marija Zecevic join. Cambridge, Massachusetts-based Proteostasis Therapeutics has bolstered its leadership team with three new appointments. ... Lastly, Dr Marija Zecevic takes on the role of vice president of
More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Gilead agrees $21bn buyout of Immunomedics
- Regeneron launches phase 3 COVID-19 antibody trial in the UK
- FDA approves Roche’s Actemra COVID-19 trial
- Roche’s Ocrevus boasts positive long-term data in MS
- First patients dosed with COVID-19 vaccine from SpyBiotech and Serum Institute of India
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
- InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
- Envision Pharma Group scoops two Silvers at the PM Society Digital Awards 2020
- Alone we can do so little, together we can do so much
- What can't we afford to treat anymore?
- OPEN VIE is awarded a Bronze Award at the PM Society Digital Awards 2020
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
PMHub
Create Health
A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...
Latest intelligence
- InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
- Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
- Alone we can do so little, together we can do so much
- Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
- 7 important considerations for creating an inclusive clinical trial website
- You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...
Quick links
Infographics
